CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,930 enrolled
Drug / intervention
Implantation of a QuickFlex® μ Model 1258T LV Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01179477
NCT01179477N/ACompleted
CompareCT.gov

QuickFlex® μ Model 1258T Left Heart Pacing Lead Post Approval Study

Abbott Medical Devices·observational·Posted Aug 11, 2010·Updated Aug 12, 2019

In Brief

An observational study evaluating Implantation of a QuickFlex® μ Model 1258T LV Lead for Heart Failure. Completed, enrolled 1,930 participants across 77 sites.

Detailed Summary

The purpose of this multicenter post-approval study is to evaluate the acute and chronic performance of the QuickFlex® μ 1258T left ventricular (LV) lead.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 11, 2010
Enrollment StartSep 1, 2010
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 15.9 years ago

Interventions

Implantation of a QuickFlex® μ Model 1258T LV Leaddevice

Implantation of a QuickFlex® μ Model 1258T LV Pacing Lead